- Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence2021 | 2. lékařská fakulta, 1. lékařská fakulta
- Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: A large patient cohort study2017 | 2. lékařská fakulta
- Disease evolution and response to rapamycin in Activated Phosphoinositide 3-Kinase delta syndrome: the european society for immunodeficiencies-Activated Phosphoinositide 3-Kinase d syndrome registry2018 | 2. lékařská fakulta
- Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase delta syndrome2014 | 2. lékařská fakulta
- Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib2017 | 2. lékařská fakulta
- Onemocnění gastrointestinálního traktu u nemocných s primárními imunodeficity2017 | Lékařská fakulta v Hradci Králové
- Randomized, Placebo-Controlled, Phase 3 Trial of PI3Kδ Inhibitor Leniolisib for Activated PI3Kδ Syndrome2023 | 2. lékařská fakulta